These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 6883933

  • 1. Steady-state salicylate plasma and urinary metabolite concentrations from plain, buffered, or enteric-coated aspirin.
    Allen JH, Thakker KM, Small RE, Wood JH, Willis HE.
    Clin Pharm; 1983; 2(1):64-6. PubMed ID: 6883933
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Serum salicylate concentrations after aspirin administration at 6- or 12-hour intervals.
    Butler CD, Straughn AB.
    Clin Pharm; 1982; 1(5):458-60. PubMed ID: 7184679
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Plasma salicylate concentrations following chronic administration of aspirin as conventional and sustained-release tablets.
    Wiseman EH.
    Curr Ther Res Clin Exp; 1969 Nov; 11(11):681-9. PubMed ID: 4982303
    [No Abstract] [Full Text] [Related]

  • 9. Comparative bioavailability of sustained-release and uncoated aspirin tablets.
    Karahalios WJ, Sawyer WT, Rittase RA, Maynard SA.
    Am J Hosp Pharm; 1981 Nov; 38(11):1754-6. PubMed ID: 7304632
    [Abstract] [Full Text] [Related]

  • 10. Serum salicylate concentrations and endoscopic evaluation of the gastric mucosa in dogs after oral administration of aspirin-containing products.
    Lipowitz AJ, Boulay JP, Klausner JS.
    Am J Vet Res; 1986 Jul; 47(7):1586-9. PubMed ID: 3740630
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Analgesics; the use of aspirin in dogs; effects of tablet type and food intake on plasma salicylate level].
    Nap RC, Breen DJ, Lam TJ, Peters IO, Willemsen A, De Bruyne JJ.
    Tijdschr Diergeneeskd; 1993 Jul 15; 118(13):439-42. PubMed ID: 8346511
    [Abstract] [Full Text] [Related]

  • 13. Effect of cimetidine on bioavailability of enteric-coated aspirin tablets.
    Paton TW, Walker SE, Leung FY, Little AH.
    Clin Pharm; 1983 Jul 15; 2(2):165-6. PubMed ID: 6883946
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interaction of omeprazole with enteric-coated salicylate tablets.
    Nefesoglu FZ, Ayanoglu-Dülger G, Ulusoy NB, Imeryüz N.
    Int J Clin Pharmacol Ther; 1998 Oct 15; 36(10):549-53. PubMed ID: 9799060
    [Abstract] [Full Text] [Related]

  • 16. [In vivo drug release from microencapsulated acetylsalicylic acid with simultaneous alcohol uptake].
    Frömming KH, Schwabe L.
    Arzneimittelforschung; 1980 Oct 15; 30(5):836-9. PubMed ID: 7190431
    [Abstract] [Full Text] [Related]

  • 17. A comparison of enteric-coated aspirin granules with plain and buffered aspirin: a report of two studies.
    Petroski D.
    Am J Gastroenterol; 1986 Jan 15; 81(1):26-8. PubMed ID: 3942122
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of an enteric coated aspirin preparation.
    Day RO, Paull PD, Champion GD, Graham GG.
    Aust N Z J Med; 1976 Feb 15; 6(1):45-50. PubMed ID: 1065299
    [Abstract] [Full Text] [Related]

  • 19. Metabolism of salicylate during chronic aspirin therapy.
    Rumble RH, Brooks PM, Roberts MS.
    Br J Clin Pharmacol; 1980 Jan 15; 9(1):41-5. PubMed ID: 7356892
    [Abstract] [Full Text] [Related]

  • 20. The effects of enteric coating of aspirin tablets on occult gastrointestinal blood loss.
    Howe GB, Champion GD, Corrigan AB, Hewson J, Haski A, Day RO, Paull PD, Graham GG.
    Aust N Z J Med; 1977 Dec 15; 7(6):600-4. PubMed ID: 350214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.